药品名称VERMOX
申请号017481产品号001
活性成分MEBENDAZOLE市场状态停止上市
剂型或给药途径TABLET, CHEWABLE;ORAL规格100MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构JANSSEN PHARMACEUTICALS INC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
017481045AP1998/10/20Control Supplement
017481044AP1998/07/27Package Change
017481043AP1998/05/20Control Supplement
017481042AP1998/03/20Manufacturing Change or Addition
017481041AP1995/09/27Manufacturing Change or Addition
017481040AP1994/06/16Control Supplement
017481038AP1998/02/13Labeling Revision
017481037AP1993/12/23Control Supplement
017481036AP1993/01/28Manufacturing Change or Addition
017481035AP1993/01/28Manufacturing Change or Addition
017481034AP1989/09/28Labeling Revision
017481032AP1986/01/26Control Supplement
017481031AP1984/08/09Manufacturing Change or Addition
017481029AP1984/08/31Manufacturing Change or Addition
017481028AP1984/05/14Labeling Revision
017481027AP1983/03/16Manufacturing Change or Addition
017481026AP1983/03/16Manufacturing Change or Addition
017481025AP1983/07/11Labeling Revision
017481024AP1981/06/04Control Supplement
017481023AP1980/12/29Control Supplement
017481020AP1980/04/03Formulation Revision
017481019AP1980/04/01Manufacturing Change or Addition
017481018AP1980/04/01Manufacturing Change or Addition
017481016AP1979/03/08Labeling Revision
017481014AP1979/03/08Manufacturing Change or Addition
017481013AP1979/09/13Manufacturing Change or Addition
017481012AP1979/02/15Manufacturing Change or Addition
017481011AP1978/10/27Manufacturing Change or Addition
017481010AP1978/04/24Manufacturing Change or Addition
017481009AP1977/08/24Labeling Revision
017481008AP1977/07/29Labeling Revision
017481007AP1977/03/04Labeling Revision
017481006AP1976/03/18Labeling Revision
017481005AP1975/10/30Control Supplement
017481004AP1975/10/30Control Supplement
017481003AP1976/03/18Control Supplement
017481000AP1974/06/28Approval